Longeveron Inc. (LGVN) stock
LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)
Close on Nov 18, 2026Market cap $61.21MP/E –Yield –
Longeveron enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Longeveron's enterprise value was $53.72B on Nov 11, 2026, against $80.08B a year earlier. Over the last 5 years it ranged from $109.09M to $529.41B, with a median of $54.74B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $53.72B | -12.0% |
| 2025 | Dec 31, 2025 | $61.05B | -43.6% |
| 2024 | Dec 31, 2024 | $108.16B | +38357.3% |
| 2023 | Dec 29, 2023 | $281.25M | -55.5% |
| 2022 | Dec 30, 2022 | $631.84M | -99.9% |
| 2021 | Dec 31, 2021 | $529.41B | – |
See a number that looks wrong?